1 , 3 Use of liraglutide 3.0 mg, another GLP1RA, approved for treatment of overweight or obesity, can also result in mildormoderate GI AEs of a nature similar to those reported in the STEP trials, primarily during initial dose escalation
When combined with semaglutide (as CagriSema), it has demonstrated additive weight loss effects beyond either compound alone
Thank you so much your support means the world, and it allows me to continue doing this work I love
Mistake 8: Not Checking for Allergies or Contraindications Check with your doctor whether Retatrutide is safe for you, especially if you take other medications or have underlying health conditions
The Role of Genetics in GLP-1 Response Recent research highlights genetic variants in the GLP1R gene (such as rs6923761), GIPR gene (rs1800437), FTO (rs9939609), and MC4R (rs17782313) that may influence appetite regulation, weight set-point, and medication response